Rojkjaer Lisa bought RIGL
February 17, 2026 · Form 4 insider transaction
Rojkjaer Lisa bought 18,894 shares of Rigel Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
18,894
Price
$0.00
Total value
N/A
InsiderRojkjaer Lisa
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 17, 2026
Filing dateFebruary 19, 2026
Shares owned after34,853
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares of common stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall vest quarterly over three (3) years, with the first quarterly vest occurring on March 31, 2026.